IQVIA (NYSE:IQV) had its target price increased by Mizuho from $290.00 to $300.00 in a report released on Monday morning, Price Targets.com reports. Mizuho currently has a buy rating on the medical research company’s stock.
IQVIA (NYSE:IQV) had its target price increased by Mizuho from $290.00 to $300.00 in a report released on Monday morning, Price Targets.com reports. Mizuho currently has a buy rating on the medical research company’s stock.